The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
Crossref DOI link: https://doi.org/10.1007/s11060-015-2025-5
Published Online: 2015-12-31
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blumenthal, D. T.
Mendel, L.
Bokstein, F.
Text and Data Mining valid from 2015-12-31